John T. Curnutte, Executive Vice President at PORTOLA PHARMACEUTICALS INC (PTLA), sold 60,000 shares at $55.47 ($3.5M) on 2017-06-26, disclosed to the SEC on 2017-06-28.
Open-market sale of $3.5M PTLA by Executive Vice President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.47 | 6,159 | $342K | 9.8% |
| 2 | $56.71 | 11,356 | $644K | 18.5% |
| 3 | $57.24 | 10,729 | $614K | 17.7% |
| 4 | $58.35 | 17,954 | $1.0M | 30.2% |
| 5 | $59.33 | 3,802 | $226K | 6.5% |
| 6 | $60.00 | 10,000 |
| $600K |
| 17.3% |
| Total | $57.88 avg | 60,000 | $3.5M | 100% |
| Filing → |
| PTLA | SELL | 2015-06-22 | $475K | — | Filing → |
| PTLA | SELL | 2015-06-17 | $450K | — | Filing → |
| PTLA | SELL | 2015-05-29 | $425K | — | Filing → |